MedTrace Logo

Augmenting Exposure Therapy for Social Anxiety With Transcranial Direct Current Stimulation

NCT03743571 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2026-04-08

Study results available
· View outcomes & findings →

Summary

This study will examine whether transcranial direct current stimulation (tDCS) can be used to improve outcomes from exposure therapy for social anxiety disorder, and facilitate extinction of fear responding toward individuals outside one's own ethnic group (i.e., ethnic out-group members).

Conditions

  • Social Anxiety

Interventions

DEVICE

transcranial direct current stimulation

tDCS will be applied over EEG coordinate FpZ to target mPFC activation during exposure therapy

BEHAVIORAL

exposure therapy

participants will complete one session of exposure therapy for fear of public speaking, which will involve providing speeches to audiences in virtual reality

Sponsors & Collaborators

  • University of Nevada, Reno

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-02
Primary Completion
2020-03-05
Completion
2020-03-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03743571 on ClinicalTrials.gov